ALLT Allot
Allot earnings company data as of 4:47 AM ET 10/25
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 19 Nov | EPS | 0.05 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by ALLT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $677K sold by 5 insiders outside a trading plan
- $210K sold by 1 insider under 10b5-1 plans
-
Boaz Grossman Senior Vice President R&DSale$31K 4,000 shares at $7.80 2.2% of stakeTraded Aug 28 Filed Aug 31
-
Boaz Grossman Senior Vice President R&DSale$45K 6,000 shares at $7.45 3.1% of stakeTraded Aug 21 Filed Aug 24
-
Gili Groner Chief Human Resources OfficerPlanned sale$210K 26,666 shares at $7.86 31% of stakeTraded Aug 18 Filed Aug 19
-
Eyal David Harari CEOSale$222K 29,111 shares at $7.64 2.6% of stakeTraded Aug 6 Filed Aug 10
-
Inbar Charash General CounselSale$4,335 556 shares at $7.80 1.9% of stakeTraded Aug 3 Filed Aug 4
-
Mark Shteiman Chief Product OfficerSale$15K 2,000 shares at $7.50 0.9% of stakeTraded Jun 15 Filed Jun 16
-
Noam Lelah SVP Customer Success & OpsSale$178K 21,000 shares at $8.48 11% of stakeTraded Jun 1 Filed Jun 2
-
Mark Shteiman Chief Product OfficerSale$82K 11,000 shares at $7.49 4.9% of stakeTraded May 21–22 Filed May 26
-
Boaz Grossman Senior Vice President R&DSale$37K 5,000 shares at $7.37 2.5% of stakeTraded May 20 Filed May 21
-
Mark Shteiman Chief Product OfficerSale$37K 5,000 shares at $7.32 2.2% of stakeTraded May 19 Filed May 20
-
Mark Shteiman Chief Product OfficerSale$21K 3,000 shares at $7.13 1.3% of stakeTraded May 18 Filed May 19
-
Inbar Charash General CounselSale$4,114 556 shares at $7.40 1.9% of stakeTraded May 1 Filed May 4
Also filed in the last 12 months, not counted as buying or selling: 1 stock grant.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13D | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F/A | Filing Doc | ||
| 20-F | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.